Télécharger le supplément (250 p.) - KCE

18 Médecine à l’acte/médecine au forfait – ANNEXES KCE Reports 85 S
In the last 14 months, record of referral to a chiropodist where feet are “at risk”
(age over 65, immobility, nephropathy, retinopathy, < 2 foot pulses) (9)
Critères relatifs aux indicateurs de processus : Inspection des pieds au cours des
3 derniers mois (27,30)
Diabetes quality indicator : foot exam in the previous 12 months (29)
Diabetic management : annual foot examination (28)
Record of diabetes management education information for patients with diabetes.
(1)
The record show that each newly diagnosed patient or carer has been offered
education about diabetes management (9)
Adequate patient information should be available in a suitable format for patient
self-management of diabetes (10)
Past 5 years record of : documentation of education about diabetes (12)
All diabetic patients should have weight record every 6 months (1)
Past 14 months, record of weight (9,12)
Recording of risk factors: Weight/BMI (targeted standards: 100%) (7)
Uit het patientendossier blijkt dat driemaandelijks BMI bepaald wordt
(procesindicator) (22)
The patient has been given advice about weight reduction or reffered to a
dietician where the patient is obese or has a BMI of > 27 (9)
Critères relatifs aux indicateurs de processus : Contrôle du poids du patient au
cours des 3 derniers mois (27,30)
80% diabetic patients (insulin dependant and NIDDM) reviewed in past year (10)
% of patients seen for follow-up (8)
Diabetic patients should be seen by an appropriate health care professionnel (GP,
Practice nurse, Diabetic Dr) annually. (2,3)
Critères relatifs aux indicateurs de processus : Prochain rendez-vous prévu dans
les 3 mois (27,30).
LDL cholesterol control: percentage of patient with most recent LDL < 130
mg/dl (4)
If the total cholesterol is > 7,8 (or > 6,4 in patients who have evidence of
ischaemic heart disease), lipid lowering treatment has been offered or
intensified (9)
Diabetic patients with established Ischeamic Heart Disease and a raised fasting
cholesterol (>=5 mmol/L) should be advised about dietary modification, or
take lipid lowering medication. (2,3)
En LDL-cholesterol van meer dan 130 mg/dL gaat gepaard met het gebruik van
lipidenverlagers (procesindicator) (23)
Diabetes quality indicator : LDL cholesterol < 100 mg/dL (29)
% patients with microalbuminaemia not on ACE inhibitor (11)
If patient is being treated for hypertension and has proteinuria (macroalbuminuria
but not microalbuminuria), the patient is taking an angiotensin converting
enzyme inhibitor (9,12)